Plexus reported first-quarter adjusted earnings of $1.78 per share, surpassing the Zacks Consensus Estimate of $1.77 and marking a 2.9% increase from $1.73 per share in the year-ago quarter. Revenue for the period rose 9.8% year-over-year to $631 million, driven by strong demand in key end markets and a favorable product mix. Operating margin expanded by 50 basis points to 8.2%, reflecting disciplined cost management and improved absorption of fixed overheads.

The Americas region generated $345 million in revenue, up 7.2% year-over-year, supported by robust growth in industrial and medical device programs. Asia-Pacific revenues climbed 12.4% to $210 million, propelled by newly launched electronics manufacturing services (EMS) programs in China and Malaysia. European operations contributed $76 million, a 5.6% increase, with strength in test and measurement equipment assembly.

During the quarter, Plexus secured $150 million in new manufacturing program awards, including two major life sciences contracts valued at $45 million and $30 million respectively. Total backlog expanded to $1.2 billion, up 15% sequentially, providing multi-year revenue visibility and underscoring the company’s success in winning higher-complexity, higher-margin programs.